Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone”

4,647 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,647 results

Not applicableUnknownNCT04778865
What this trial is testing

Effect of Treatment for Vitamin D Deficiency on Thyroid Function and Autoimmunity in Hashimoto's Thyroiditis.

Who this might be right for
Hashimoto DiseaseTreatment LevothyroxineVitamin D Deficiency
Universidad de Valparaiso 50
Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Not applicableUnknownNCT03818100
What this trial is testing

Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible

Who this might be right for
Breast Cancer
CCTU- Cancer Theme 43
Early research (Phase 1)Study completedNCT06797505
What this trial is testing

A Bioequivalence Study of Two Different PEG-rhGH Preparations

Who this might be right for
Pediatric Growth Hormone Deficiency (PGHD)
Changchun GeneScience Pharmaceutical Co., Ltd. 87
Not applicableLooking for participantsNCT06993805
What this trial is testing

Evaluating a Our Practice Advisory (OPA) to Optimize Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Test Orders

Who this might be right for
Physician WorkflowResource Utilization
University of California, Los Angeles 384
Testing effectiveness (Phase 2)Study completedNCT00140348
What this trial is testing

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Who this might be right for
Prostate Cancer
Cell Genesys 80
Testing effectiveness (Phase 2)Ended earlyNCT00597597
What this trial is testing

Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Rush University Medical Center 11
Not applicableStudy completedNCT00668252
What this trial is testing

Circulating Endothelium Progenitor Cells and Endogenous Oestrogen in Healthy Subjects

Who this might be right for
Healthy
Assistance Publique - Hôpitaux de Paris 48
Not applicableWithdrawnNCT01314508
What this trial is testing

Increlex Treatment of Children With Chronic Liver Disease and Short Stature

Who this might be right for
Growth FailureChronic Liver Disease
University of California, Los Angeles
Testing effectiveness (Phase 2)Looking for participantsNCT06361940
What this trial is testing

Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 100
Large-scale testing (Phase 3)Ended earlyNCT00174291
What this trial is testing

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

Who this might be right for
Endocrine System Diseases
Pfizer 21
Testing effectiveness (Phase 2)Study completedNCT02023918
What this trial is testing

Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes

Who this might be right for
DiabetesMetabolic SyndromeInsulin Resistance
University of California, San Francisco 6
Not applicableStudy completedNCT03408678
What this trial is testing

Determinants of Type 2 Diabetes Risk in Middle-aged Black South African Men and Women

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceMenopause+1 more
University of Witwatersrand, South Africa 1,025
Testing effectiveness (Phase 2)Study completedNCT03822468
What this trial is testing

Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 376
Not applicableUnknownNCT00790348
What this trial is testing

Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes

Who this might be right for
Type 2 Diabetes
Wayne State University 45
Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Very early researchStudy completedNCT02640976
What this trial is testing

Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

Who this might be right for
Infertility
Cairo University 216
Not applicableUnknownNCT05835089
What this trial is testing

Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases

Who this might be right for
Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
Sohag University 50
Large-scale testing (Phase 3)Ended earlyNCT01497197
What this trial is testing

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Who this might be right for
InfertilityFertilityFollicle Stimulating Hormone Deficiency
Merck KGaA, Darmstadt, Germany 174
Testing effectiveness (Phase 2)WithdrawnNCT05234606
What this trial is testing

A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

Who this might be right for
Urothelial CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer+2 more
Silverback Therapeutics
Load More Results